DIEX Recherche is proud to announce the opening of its fourth research center in Quebec. CEO Suzie Talbot made the announcement at DIEX Recherche in Sherbrooke. She insists that it is important to have good news to share these days. The opening of a new center will provide the local population of this beautiful region with innovative clinical trials.
Read MoreNew information on COVID-19 emerges every day. Researchers and scientists in Canada and around the world are working hard to better understand the virus, and its impacts on people and communities. By keeping pace with this information, we can better protect the health of Canadians and set our country on the path to recovery.
Read MoreGlycovax Pharma, a biopharmaceutical company based in Montréal, is actively working on the development of a new vaccine approach to counter COVID-19. The prototype glycoconjugate vaccine is currently in the preclinical phase.
Read MoreNew features, including fever, symptom and medication tracking, are now available for free to first-time users to support high-risk populations navigating COVID-19.
Read MoreRoche Canada is pleased to announce the launch of the Roche Data Science Coalition, a group of like-minded public and private organizations committed to working with the global community to develop solutions to the challenges of the COVID-19 pandemic. The collaborators in the Coalition include: Alberta Machine Intelligence Institute (Amii), doc.ai, NVIDIA, Self Care Catalysts, ThinkData Works Inc and Vector Institute.
Read MoreLaurent Pharmaceuticals Inc., a clinical-stage biopharmaceutical company that spun off from McGill University in 2012, today announces that it is planning to test its lead drug LAU-7b in patients with COVID-19 disease, as part of a Phase 2 clinical trial.
Read MoreTetra Bio-Pharma Inc., a leader in cannabinoid-derived drug discovery and development has joined the battle to fight the novel COVID-19 virus. The Company will mobilize its expertise in regulatory affairs and quality assurance to support Canadian businesses seeking Health Canada approval for specific products used to mitigate the ongoing COVID-19 pandemic.
Read MoreThe humanitarian costs of the coronavirus outbreak continue to mount, with more than 845,000 people infected globally. The number of people confirmed to have died having the virus has now surpassed 41,500.
Read MoreJAMP Pharma Group, a Canadian pharmaceutical company, announced today that it is donating one million doses of hydroxychloroquine to Canadian hospitals, a drug that is normally used to treat malaria and rheumatoid arthritis and which could potentially be useful in treating hospitalized patients infected with the COVID-19 virus.
Read MoreIMV Inc. announced that it is advancing the clinical development of a DPX-based vaccine candidate against COVID-19. Vaccines against infectious disease have been a core part of IMV’s heritage across its DPX platform technology.
Read More
